ΜΕΤΑΛΑΞΗ SARS COV 2-ΑΠΟΤΕΛΕΣΜΑΤΙΚΟΤΗΤΑ ΕΜΒΟΛΙΟΥ PFIZER BIONTECH
n a small-scale study, researchers from the Department of Biochemistry and Molecular Biology, University of Texas, US, have tested antibodies generated by 20 patients given the BNT162b2 (i.e., the Pfizer vaccine) against a laboratory-developed isogenic COVID-19 variant that contained mutations in the N501 and Y501 regions and which is similar to the South African variant.…
Details